Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03160547 · ClinicalTrials.gov registry record · NA
The Effect of Higher Protein Dosing in Critically Ill Patients
A NA study of Critical Illness and Malnutrition, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,329
- Enrollment target
- 20
- Study locations
NCT03160547: Completed NA study of Critical Illness and Malnutrition, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
NCT03160547 is a NA study of Critical Illness and Malnutrition that has completed, run by Clinical Evaluation Research Unit at Kingston General Hospital. The registered enrollment target is 1,329 participants, below the 3,124-participant average among 91 other Critical Illness trials with a reported enrollment target (57% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03160547, a NA study of Critical Illness and Malnutrition, has completed, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,329 participants
- Enrollment target
- 20
- Study locations
Study Summary
The investigator will investigate the effects of higher protein/amino acid dosing (≥2.2 g/kg/d) vs usual protein/amino acid dosing (≤1.2 g/kg/d) on clinical outcomes in nutritionally high risk ill patients.
Primary Outcome
This is a composite of mortality and length of stay, evaluated up to 60 days post randomization
Conditions Studied
Interventions
- OTHER Usual Protein/Amino Acid Group
- OTHER Higher Protein/Amino Acid Group
Study Locations (20)
New Jersey
- Virtua - Marlton
- Virtua - Mount Holly
- Virtua - Voorhees Township
Arizona
- Banner University Medical Center - Phoenix
- Phoenix VA Health Care System - Phoenix
Illinois
- NorthShore University HealthSystem - Evanston
- SwedishAmercian.Hospital - Rockford
Ohio
- The Ohio State University Wexner Medical Center - Columbus
- Fairfield Medical Center - Lancaster
Tennessee
- University of Tennessee Medical Center Knoxville - Knoxville
- Vanderbilt University Medical Center - Nashville
Washington
- Harborview Medical Center - Seattle
- Legacy Salmon Creek Medical Center - Vancouver
California
- MemorialCare Long Beach Medical Center - Long Beach
Indiana
- IU Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,329 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2021-12-03 |
| Phase | NA |
What the finished NCT03160547 record still lists
NCT03160547 is an interventional study that assigns participants to a tested intervention. Its 1,329 participants enrollment target places it among the larger protocols in the corpus, below the 3,124-participant average among 91 other Critical Illness trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Usual Protein/Amino Acid Group is the first listed.
NCT03160547 names 20 study sites across 13 states, led by New Jersey, Arizona, Illinois.
Frequently Asked Questions
What is clinical trial NCT03160547 about?
NCT03160547 is a clinical study titled "The Effect of Higher Protein Dosing in Critically Ill Patients". The investigator will investigate the effects of higher protein/amino acid dosing (≥2.2 g/kg/d) vs usual protein/amino acid dosing (≤1.2 g/kg/d) on clinical outcomes in nutritionally high risk ill patients.
What is the current status of trial NCT03160547?
This trial is currently completed. It is a NA study. The enrollment target is 1,329 participants. The study started on 2017-11-21. Estimated completion is 2021-12-03.
What conditions does trial NCT03160547 study?
This clinical trial studies the following conditions: Critical Illness, Malnutrition.
What interventions are being tested in trial NCT03160547?
The interventions under investigation include: Usual Protein/Amino Acid Group (OTHER), Higher Protein/Amino Acid Group (OTHER).
Who is sponsoring clinical trial NCT03160547?
This trial is sponsored by Clinical Evaluation Research Unit at Kingston General Hospital, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03160547 being conducted?
This trial has 20 study locations across Arizona, California, Illinois, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03160547's enrollment target sits among peer trials
1,329 17th of 91 higher than 75 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
PUSH-IT Continuing Enteral Feeds for Tracheostomy
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05536011 · 1,329 participants
WAKIX® (Pitolisant) Pregnancy Registry
- NCT05889182 · 1,328 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI